Bowel screening helps to detect early cancers before they become deadly, study finds

November 5, 2012 in Cancer

Bowel screening helps to detect early cancers before they have the power to kill

(Medical Xpress)—Bowel screening is detecting more cancers when they are less mature and have less aggressive biological characteristics according to new research presented at the NCRI Cancer Conference in Liverpool this week.

The research shows that screening is not only able to pick up more early stage bowel cancer but also that more whose cancer is picked up via screening were found to have fewer of the characteristics which make it more likely to have spread. This includes when the tumour grows into in the patients tissue surrounding the , making it more likely to go on to spread.

Doctors from the University of Glasgow examined 394 bowel in Scotland, 288 whose cancer was diagnosed through screening compared with 106 whose cancer was not detected through screening.

They found that patients diagnosed through screening were more likely to be younger, have earlier stage disease, were less likely to be anaemic and were less likely to have the biological characteristics that give tumours the power to spread.

In particular, patients were also less likely to have high levels of in their blood (modified Glasgow Prognostic Score). A raised modified Glasgow Prognostic Score is a feature that has recently been shown to predict poorer outcome following a of bowel cancer.

Dr David Mansouri, study author and Clinical Research Fellow at the University of Glasgow, said: "Our new study tells us that as well as the bowel cancers being picked up through screening being less likely to have spread by the time they are diagnosed, there were also more patients with features that may increase the chances of survival. It adds to what we already know about the benefits of bowel screening and shows there may well be other advantages to . The next step will be to repeat our work with a larger number of patients."

Dr Jane Cope, director of the NCRI, said: "Deaths from bowel cancer are still very high in the UK – more than 16,000 a year – and only around half of patients survive their disease for more than ten years. But we also know that when bowel cancer is found at the earliest stage, there is an excellent chance of survival and more than 90 per cent of people survive at least five years. So early diagnosis is crucial, and it's important we find out as much we can about the disease so that more lives can be saved."

is the third most common cancer with more than 41,000 people diagnosed with the disease each year.

More information: www.ncri.org.uk/nc… cts/A19.html

Provided by Cancer Research UK search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Small cancer risk following CT scans in childhood and adolescence confirmed

The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...

Cancer created 3 hours ago | popularity not rated yet | comments 0

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

Cancer created 4 hours ago | popularity not rated yet | comments 0

Novel RNA-based classification system for colorectal cancer

A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine this w ...

Cancer created 5 hours ago | popularity not rated yet | comments 0

Low radiation scans help identify cancer in earliest stages

A study of veterans at high risk for developing lung cancer shows that low-dose computed tomography (LDCT) can be highly effective in helping clinicians spot tiny lung nodules which, in a small number of patients, may indicate ...

Cancer created 6 hours ago | popularity not rated yet | comments 0

Poliovirus vaccine trial shows early promise for recurrent glioblastoma

An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.

Cancer created 8 hours ago | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.